TEVA - Teva- Pharmaceutical Industries Ltd. - ADR
Close
18.87
0.140 0.742%
Share volume: 10,069,878
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.73
0.14
0.75%
Fundamental analysis
32%
Profitability
26%
Dept financing
50%
Liquidity
47%
Performance
29%
Performance
5 Days
1.67%
1 Month
14.99%
3 Months
11.66%
6 Months
44.16%
1 Year
94.74%
2 Year
108.74%
Key data
Stock price
$18.87
DAY RANGE
$18.67 - $18.87
52 WEEK RANGE
$8.06 - $18.89
52 WEEK CHANGE
$0.92
DIVIDEND
$0.085
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Kaare Schultz
Region: US
Website: http://www.tevapharm.com
Employees: 37,736
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.tevapharm.com
Employees: 37,736
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Recent news